Manas Resources EBITDA margin
Cos'è EBITDA margin di Manas Resources?
EBITDA margin di Manas Resources Limited è -1,983.95%
Qual è la definizione di EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin di aziende nel Materials settore su ASX rispetto a Manas Resources
Cosa fa Manas Resources?
Manas Resources Limited engages in the acquisition, exploration, evaluation, and development of gold properties in Australia. Its principal properties include the Mbengué project that covers an area of approximately 400 square kilometers; Eburnea project; and Gonsan project comprising 3 exploration permit applications covering a combined area of approximately 1,000 square kilometers located in Côte D'Ivoire. Manas Resources Limited was incorporated in 2007 and is based in Mount Hawthorn, Australia.
Aziende con ebitda margin simili a Manas Resources
- AFC plc ha EBITDA margin di -2,006.21%
- AFC plc ha EBITDA margin di -2,006.21%
- Shree Minerals ha EBITDA margin di -1,996.58%
- Mirati Therapeutics Inc ha EBITDA margin di -1,991.78%
- Nanoveu ha EBITDA margin di -1,986.23%
- Helius Medical Technologies Inc ha EBITDA margin di -1,984.85%
- Manas Resources ha EBITDA margin di -1,983.95%
- Fourth Wave ha EBITDA margin di -1,972.64%
- Skychain Technologies ha EBITDA margin di -1,970.98%
- DBV Technologies ha EBITDA margin di -1,960.96%
- Sultan Resources ha EBITDA margin di -1,947.34%
- Kronos Bio ha EBITDA margin di -1,945.08%
- Havn Life Sciences Inc ha EBITDA margin di -1,929.90%